MitoDys Therapeutics ltd
Big Data and informatics-derived multi-targeted drugs as disease modifying agents for neurodegenerative diseases.
Mitodys is a capital-efficient drug discovery start-up focused on uncovering proprietary drugs with profiles that allow them to be repositioned to a new indication. Its focus is on the discovery of disease-modifying agents for the treatment of neurodegenerative diseases using a systems-targeted approach which represents a new paradigm in drug discovery. The diseases targeted remain poorly- or unmet needs valued in the billions of US dollars.